Home ›
Trademark Categories ›
Medical Apparatus ›
1998 ›
IN ›
INNOLET
Trademark search for:
INNOLET
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
1998-07-07 — Application filed
1999-03-09 — Assigned to examiner
1999-03-16 — Final disposition recorded
1999-09-09 — Correspondence received in law office
1999-10-18 — Sec. 1(b) claim deleted
1999-11-24 — Approved for pub - principal register
2000-01-21 — Notice of publication
2000-02-22 — Published for opposition
2000-05-16 — Registered-principal register
2006-03-27 — Case file in ticrs
2006-05-15 — Teas section 8 received
2006-05-15 — Registered - sec. 8 (6-yr) filed
2006-08-09 — Assigned to paralegal
2006-08-09 — Registered - sec. 8 (6-yr) accepted
2006-12-07 — Cancellation instituted no. 999999
2007-07-05 — Cancellation denied no. 999999
2007-07-05 — Cancellation terminated no. 999999
2008-03-06 — Counterclaim opp. no. 999999
2010-04-22 — Teas revoke/app/change addr of atty/dom rep received
2010-04-22 — Attorney/dom.rep.revoked and/or appointed
2011-08-25 — Teas change of correspondence received
2011-11-11 — Teas change of correspondence received
2014-06-27 — Cancelled sec. 8 (10-yr)/expired section 9
2014-06-27 — Final status recorded
Owner Information
Novo Nordisk A/S
DK-2880 Bagsvaerd DK
Novo Nordisk A/S
DK-2880 Bagsvaerd DK
Novo Nordisk A/S
DK-2880 Bagsvaerd DK
Correspondent
Paul Fields Leason Ellis LLP One Barker Avenue, Fifth Floor White Plains, NY 10601 UNITED STATES
Filing Details
Filing Date:
1998-07-07
Status Date:
2014-06-27
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.